about
Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitisInhibition of NADH oxidation by chloramphenicol in the freely moving rat measured by picosecond time-resolved emission spectroscopy.A synthetic mammalian gene circuit reveals antituberculosis compounds.Metronidazole-induced encephalopathy: a case report and review of the literature.Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy.[Acute interstitial nephritis following piperacillin].Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinonesMeperidine misuse in a patient with sphincter of Oddi dysfunction.Acute porphyria in a patient with Arnold Chiari malformation.Neurotoxic effects associated with antibiotic use: management considerationsPrescribed drugs and neurological complicationsNeurotoxicity induced by beta-lactam antibiotics: from bench to bedside.Antiinfective agents affecting cognition: a review.A guide to the management of tuberculosis in patients with chronic liver disease.Hepatotoxic effects of therapies for tuberculosis.Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics.Secondary psychoses: an update.Delirium in hospitalized elderly.Drug-induced cerebellar ataxia: a systematic review.Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.Determination of ticarcillin levels in serum by high-pressure liquid chromatography.A mimic's imitator: a cavitary pneumonia in a myasthenic patient with history of tuberculosis.Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia.Metronidazole induced encephalopathy in a patient with brain abscess.Prospective surveillance of imipenem/cilastatin use and associated seizures using a hospital information system.Can doxycycline cause polyneuropathy?Chloramphenicol decreases brain glucose utilization and modifies the sleep-wake cycle architecture in rats.Acute effects of tetracycline exposure in the freshwater fish Gambusia holbrooki: antioxidant effects, neurotoxicity and histological alterations.MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings.Adverse drug reactions and treatment outcome analysis of DOTS-plus therapy of MDR-TB patients at district tuberculosis centre: A four year retrospective study.Anticholinergic Accumulation: A Slumbering Interaction between Drugs and Food Supplements.Encephalopathy with myoclonic jerks resulting from ceftazidime therapy: an under-recognized potential side-effect when treating febrile neutropenia.The effect of tobramycin on the renal handling of vancomycin.Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System.Mechanical ventilation in foals with botulism: 9 cases (1989-2002).Reversible optic neuropathy due to metronidazole.A Simple Synthesis of Polyfunctionalized 4-Aminopyrazolidin-3-ones as ‘Aza-deoxa’ Analogs ofD-Cycloserine
P2860
Q28362428-043190F6-CAC3-4E8B-B0AD-8DCC0D12E1D3Q31129183-FF98AC2D-B893-4B2A-BE49-B5456A43E022Q33351251-A1996C06-3058-4823-98A3-3C47F28491DBQ33539515-11B63D4F-462D-47B0-ABF8-9B4D13124126Q33754773-A1944AF8-F6E2-465A-96E1-FD5927E543C6Q34678415-68CB8609-4416-49DB-83A4-F10B93BC8E89Q34726267-5F691A80-4A75-4E91-B71F-274B4099AEE3Q35092951-C6BC7F6B-8A93-491F-8BA1-3B853DA4EDAEQ35128606-41BE51F6-4368-4CE5-8694-D52700B0710AQ35219637-5A0AC329-6562-461A-85E9-D656DC65B382Q35576530-8F44DFE3-C2F2-4A9D-A6F8-52624F6F052CQ36302409-86FF7D0C-CB39-4568-9687-25B78A4C6BDCQ37071320-60ED328F-41BC-437B-984C-22F6351F2A36Q37613934-9B65A217-ACDD-4F81-9667-35990692ADC2Q37784382-9F37779A-4385-4AE4-B2DD-B1E4700F04E9Q38007126-17FDA6B7-0531-4B44-A7F9-BB49138EA314Q38087564-6DEC50A5-BD4E-40ED-98B8-88D4378368FDQ38139694-9493961D-FE00-4DC3-9EA1-19B4D9AD36DCQ38267726-2A79B93C-4A17-46DF-B730-E5979E499722Q39461202-77624F76-7DA4-4294-A80B-8C8BAF08A090Q39637650-C5029E17-1316-46B4-8E57-ADF7B363DA26Q39834210-4D70A3DA-4F61-4782-8E10-00AC54D94CFCQ41119852-77AEC886-ACFE-488C-9F50-364BBDC015BCQ41696202-277DE602-3335-430A-B08F-5BD9714D9AA7Q42141630-81053045-D12D-47AB-8257-C8A1A739022AQ42558610-19B733DC-1077-4149-821C-A9602210D462Q43959189-FDC5A438-0462-41ED-AFF7-B8100F0CE682Q46526773-99251A74-34E4-4FE6-8661-8BD0E3CBF9AFQ46802817-FFCB9B25-84D8-4751-871E-EBD0E5869D3BQ46989168-2D6FBA2D-2761-45E9-8874-7E724E453F51Q47105697-FA7F6B7A-0132-4DC9-A091-BF1E9F0B59AFQ48104871-A0990CAC-D1C9-400B-ACB4-C337E6FF2E56Q48259943-E99247EF-8DF4-41D3-88C4-6A735F35EC38Q50543634-4928787D-6735-48AE-8365-DFB4714FBFC5Q50876825-572EF3E1-D274-4C7C-883A-3BFFC7AFD2C6Q51650391-98710158-7E63-4EAC-90D7-B46E90428378Q55044451-CED1C5F5-B3D1-4EA2-91C2-FADA78699161Q58215885-06174F06-0BA6-471D-A46F-6C481AA6FA7E
P2860
description
1984 nî lūn-bûn
@nan
1984 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
The neurotoxicity of antibacterial agents.
@ast
The neurotoxicity of antibacterial agents.
@en
The neurotoxicity of antibacterial agents.
@nl
type
label
The neurotoxicity of antibacterial agents.
@ast
The neurotoxicity of antibacterial agents.
@en
The neurotoxicity of antibacterial agents.
@nl
prefLabel
The neurotoxicity of antibacterial agents.
@ast
The neurotoxicity of antibacterial agents.
@en
The neurotoxicity of antibacterial agents.
@nl
P1476
The neurotoxicity of antibacterial agents.
@en
P2093
P304
P356
10.7326/0003-4819-101-1-92
P407
P577
1984-07-01T00:00:00Z